Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

CT ORDER

CT ORDER
Other
9999999997-18-004970.pdf 9999999997-18-004970.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-18-010157.pdf 0000899243-18-010157.rtf View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
0000921895-18-001241.pdf 0000921895-18-001241.rtf 0000921895-18-001241.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
De Paolantonio Ernest Robert 0000899243-18-009681.pdf 0000899243-18-009681.rtf View HTML

Amendment to a previously filed 10-Q

10-Q/A
Quarterly Filings
0001193125-18-103435.pdf 0001193125-18-103435.rtf 0001193125-18-103435.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0000899243-18-008356.pdf 0000899243-18-008356.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-085992.pdf 0001193125-18-085992.rtf 0001193125-18-085992.xls View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K
Annual Filings
0001193125-18-084193.pdf 0001193125-18-084193.rtf 0001193125-18-084193.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-18-006982.pdf 0000899243-18-006982.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-073669.pdf 0001193125-18-073669.rtf 0001193125-18-073669.xls View HTML

Copyright Morningstar